KMT2D and neoplasm: Using publicly available sequencing data of human tumours, we found that in particular the catalytically active components of the MLL3/MLL4 COMPASS-like complex MLL3, MLL4 and KDM6A show a high alteration frequency that presumably lead to reduced protein expression.